Malignant hyperthermia testing in probands without adverse anesthetic reaction
Matthew A Timmins1, Henry Rosenberg, Marilyn Green Larach
1From the Malignant Hyperthermia Investigation Unit, University Health Network, Toronto, Ontario, Canada (M.A.T., C.S., N.K., S.R.); Department of Anesthesia and Pain Management, University of Toronto, Toronto, Ontario, Canada (M.A.T., C.S., N.K., S.R.); Malignant Hyperthermia Association of the USA, Sherburne, New York, and Saint Barnabas Medical Center, Medical Education, Livingston, New Jersey, and Rutgers New Jersey Medical School, Newark, New Jersey (H.R.); and North American Malignant Hyperthermia Registry, Pittsburgh, Pennsylvania (M.G.L.).
Malignant hyperthermia (MH) testing reveals positive results in many non-anesthetic cases, often linked to muscle disorders. Oral dantrolene effectively improved symptoms in most patients with positive caffeine-halothane contracture tests (CHCT).
Area of Science:
- Medical Genetics
- Pharmacology
- Neuromuscular Disorders
Background:
- Malignant hyperthermia (MH) is primarily known as an anesthetic-triggered reaction.
- However, MH-like symptoms can occur in various non-anesthetic-related disorders.
- Investigating these non-anesthetic cases is crucial for understanding MH spectrum.
Purpose of the Study:
- To investigate reasons for MH testing referrals in non-anesthetic cases.
- To assess the phenotype of patients with non-anesthetic MH-like reactions.
- To evaluate the efficacy of oral dantrolene in non-anesthetic probands with positive caffeine-halothane contracture tests (CHCT).
Main Methods:
- Retrospective analysis of probands referred for MH testing without anesthetic reactions.
- Selection of patients who underwent the caffeine-halothane contracture test (CHCT).
- Analysis of clinical details, creatine kinase (CK) levels, and response to oral dantrolene.
Main Results:
- 64% of patients referred for non-anesthetic indications tested positive for CHCT.
- Positive CHCTs were associated with high CK, exercise intolerance, chronic fatigue, and muscle weakness.
- Oral dantrolene improved musculoskeletal symptoms in 82% of CHCT-positive patients, with response linked to CK levels.
Conclusions:
- A positive CHCT may indicate disorders beyond anesthetic sensitivity.
- Muscle symptoms can manifest in individuals with positive CHCTs without anesthetic triggers.
- Oral dantrolene shows potential therapeutic benefit for these non-anesthetic related symptoms.
Related Concept Videos
Temperature Measurement Sites
Oral: When assessing oral temperature, the thermometer tip should be placed under the tongue in the posterior sublingual pocket. It offers accurate readings and can be...
Myasthenia Gravis: Diagnostic Tests
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...


